CDKN3 and cancer: It has also been shown to be upregulated in some cancer cell lines [19] and to function as an oncogenic factor by targeting the cyclin-dependent kinase inhibitor p27Kip1 [20], [21], [22]; together, these observations suggest an important role of miR-221 in cell growth regulation.